USSTOCK.TODAY
Regular Market
Log in Sign up

Xenon Pharmaceuticals shares drop approximately 40% ahead of Q3 earnings release

Earnings Whispers · ·by G4L

XENE
XENE Xenon Pharmaceuticals Inc
$40.45 +3.27%
View chart & analysis →
  1. 1Xenon shares fell approximately 40% following the report.
  2. 2Xenon is expected to report a Q3 loss per share of $1.17, according to consensus.
  3. 3Xenon Pharmaceuticals will release its Q3 earnings on November 9.

So what's the key point?

Xenon Pharmaceuticals shares fell about 40% ahead of its Q3 earnings announcement. Losses are expected to be higher than what experts predicted.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Xenon Pharmaceuticals Files for Approval and Advances Azetucalnor Clinical Trials The Motley Fool +1 · 13h agoXenon Pharmaceuticals beats market expectations despite recording third-quarter loss Associated Press +1 · 16h agoRecursion Pharmaceuticals posts Q2 loss of $131 million, missing estimates Associated Press +1 · Aug 5
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news